Henshaw Capital’s Amicus Therapeutics FOLD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-43,882
Closed -$346K 196
2025
Q3
$346K Sell
43,882
-9,073
-17% -$64.6K 0.01% 219
2025
Q2
$303K Hold
52,955
0.01% 275
2025
Q1
$432K Hold
52,955
0.02% 245
2024
Q4
$499K Hold
52,955
0.02% 221
2024
Q3
$566K Buy
52,955
+4,413
+9% +$48.1K 0.02% 205
2024
Q2
$482K Buy
48,542
+819
+2% +$8.41K 0.02% 179
2024
Q1
$562K Hold
47,723
0.03% 160
2023
Q4
$677K Buy
47,723
+4,743
+11% +$53.9K 0.04% 137
2023
Q3
$523K Buy
42,980
+15,619
+57% +$201K 0.03% 148
2023
Q2
$344K Hold
27,361
0.02% 161
2023
Q1
$303K Hold
27,361
0.02% 176
2022
Q4
$334K Hold
27,361
0.02% 164
2022
Q3
$286K Hold
27,361
0.02% 210
2022
Q2
$294K Hold
27,361
0.02% 223
2022
Q1
$259K Hold
27,361
0.02% 277
2021
Q4
$316K Hold
27,361
0.02% 254
2021
Q3
$261K Hold
27,361
0.02% 281
2021
Q2
$264K Buy
27,361
+3,406
+14% +$33.2K 0.02% 302
2021
Q1
$237K Buy
23,955
+10,430
+77% +$161K 0.02% 314
2020
Q4
$312K Buy
+13,525
New +$277K 0.02% 248

Other funds holding FOLD